Fepranon - Instructions For Use, Reviews, Analogues

Table of contents:

Fepranon - Instructions For Use, Reviews, Analogues
Fepranon - Instructions For Use, Reviews, Analogues

Video: Fepranon - Instructions For Use, Reviews, Analogues

Video: Fepranon - Instructions For Use, Reviews, Analogues
Video: Trazodone Antidepressant Review and Mnemonic for NCLEX | Side Effects (Sleep) 2024, November
Anonim

Fepranon

Instructions for use:

  1. 1. Pharmacological action
  2. 2. Release form
  3. 3. Analogs
  4. 4. Indications for use
  5. 5. Contraindications
  6. 6. Method of application
  7. 7. Side effects
  8. 8. Drug interactions
  9. 9. Storage conditions

Fepranon is an anorexigenic agent indicated for use in obesity of alimentary genesis.

pharmachologic effect

Fepranon's formula
Fepranon's formula

The active component of Fepranon has a psychostimulating effect.

The mechanism of action is based on the stimulation of the saturation center and the suppression of the hunger center. Fepranon according to the instructions, stimulating the cerebral cortex, has practically no peripheral adrenostimulating effect.

In addition, Fepranon improves metabolism and contributes to weight loss in obesity.

The pharmacodynamic effect develops an hour after taking the pills, the duration of the effect is at least eight hours.

Form of release of Fepranon

The drug Fepranon is produced in the form of 25 mg pills containing the active ingredient - amfepramone.

Fepranon's analogs

There are no analogues of Fepranon for the active substance.

The closest analogues of Fepranon in terms of the mechanism of action are the drugs Goldline, Meridia, Reduxin, Lindax and Slimia.

Indications for the use of Fepranon

According to the instructions, Fepranon is prescribed for the treatment of obesity of alimentary genesis.

In addition, Fepranon can be taken as part of a combination therapy for the treatment of adiposogenital syndrome and hypothyroidism.

Contraindications

Fepranon, according to the instructions, is contraindicated for use with:

  • Arterial hypertension;
  • Atherosclerosis;
  • Pheochromocytoma;
  • Myocardial infarction;
  • Diabetes mellitus;
  • Pituitary adenoma;
  • Epilepsy;
  • Psychosis;
  • Glaucoma;
  • Thyrotoxicosis;
  • Hypersensitivity to the active or auxiliary components of Fepranon.

Fepranone has been approved for use in pediatrics since the age of twelve.

Method of using Fepranon

Dragee Fepranon is recommended to be taken before meals (half an hour) along with a low-calorie diet. A single dosage is 1 tablet, the frequency of administration is up to three times a day. If the effect of the therapy carried out by Fepranon is insufficient, the daily dosage can be increased to four pills.

The average duration of treatment with Fepranon is six to ten weeks. The course of treatment can be repeated in three months.

Children over 12 years old are usually prescribed half the adult dosage.

Side effects of Fepranon

According to reviews, the drug Fepranon can cause the following undesirable side effects:

  • Weakness;
  • Dry mouth;
  • Tachycardia;
  • Itchy skin;
  • Insomnia;
  • Conjunctivitis;
  • Rhinitis;
  • Headache;
  • Constipation or diarrhea;
  • Euphoria;
  • Increased blood pressure;
  • Deterioration of mood;
  • Irritability;
  • Nausea;
  • Rash;
  • Vomiting;
  • Swelling of the eyelids;
  • Myalgia;
  • Polyuria;
  • Dysuria.
Analogue of Fepranon
Analogue of Fepranon

With prolonged use of Fepranon, according to reviews, a decrease in potency, alopecia, and in some cases drug dependence may occur.

When taken in high doses, Fepranon, according to reviews, can lead to the development of:

  • Hyperreflexia;
  • Tremor;
  • Confusion of consciousness;
  • Tachypnea;
  • Collapse;
  • Hallucinations;
  • Convulsions (against the background of epilepsy).

For the treatment of an overdose with Fepranon, it is recommended:

  • Forced diuresis;
  • Gastric lavage;
  • Inducing vomiting;
  • Taking psychoactive drugs (with the development of severe mental disorders) and beta-blockers (with tachycardia);
  • Artificial ventilation of the lungs (when symptoms of respiratory failure appear).

Drug interactions

Fepranone can weaken the hypoglycemic effect of insulin and the hypotensive effect of guanethidine.

The risk of developing a hypertensive crisis increases with the simultaneous use of Fepranone with MAO inhibitors.

Storage conditions

Fepranon belongs to a number of potent substances (list B) and is dispensed only by prescription. Dragee storage period is no more than 2 years.

Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!

Recommended: